STOCK TITAN

Bolt Biotherapeutics: 10% owner buys 53,094 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Bolt Biotherapeutics, Inc. (BOLT) reports that its 10% owner, Coastlands Capital LP, indirectly purchased 53,094 common shares in two transactions: 33,094 on November 16, 2026, at a weighted average of $5.8900 per share, and 20,000 on November 17, 2026, at $5.7499 per share. The November 16 purchases ranged from $5.8000 to $5.9136 per share. No Rule 10b5-1 plan is reported.

Insider Coastlands Capital LP
Role 10% Owner
Bought 53,094 shs ($310K)
Type Security Shares Price Value
Purchase Common Stock F2 20,000 $5.7499 $115K
Purchase Common Stock F1, F2 33,094 $5.89 $195K
Holdings After Transaction: Common Stock — 515,510 shares (Indirect, By Coastlands Capital LP)
Footnotes (2)
  1. F1. The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $5.8000 to $5.9136. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.
  2. F2. Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.
Shares purchased 53,094 shares Across two reported purchases
Shares purchased 33,094 shares November 16, 2026
Weighted average purchase price $5.8900 per share November 16, 2026; individual purchase prices ranged from $5.8000 to $5.9136
Shares purchased 20,000 shares November 17, 2026
Purchase price $5.7499 per share November 17, 2026
weighted average purchase price financial
"The price reported represents the weighted average purchase price per share."
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
pecuniary interest financial
"except to the extent of that person's pecuniary interest therein"
beneficial ownership financial
"disclaims beneficial ownership of common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BOLT shares did Coastlands Capital LP purchase?

Coastlands Capital LP purchased 53,094 shares in two reported transactions: 33,094 shares on November 16, 2026, and 20,000 shares on November 17, 2026.

What prices did Coastlands Capital LP pay for BOLT shares?

The November 16, 2026, purchase price was a weighted average of $5.8900 per share, with individual purchase prices ranging from $5.8000 to $5.9136. The November 17, 2026, purchase price was $5.7499 per share.

Who is Matthew Perry in the BOLT Coastlands Form 4?

Matthew Perry is identified as the control person of Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital LLC and Coastlands Capital GP LLC. The reporting persons filed jointly but not as a group and disclaim beneficial ownership except to the extent of their pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Coastlands Capital LP

(Last)(First)(Middle)
601 CALIFORNIA STREET
SUITE 1210

(Street)
SAN FRANCISCO CALIFORNIA 94108

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bolt Biotherapeutics, Inc. [ BOLT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026P33,094A$5.89(1)495,510IBy Coastlands Capital LP(2)
Common Stock11/17/2026P20,000A$5.7499515,510IBy Coastlands Capital LP(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $5.8000 to $5.9136. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the reporting persons will provide full information regarding the number of shares purchased at each separate price.
2. Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.
/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP11/17/2026
/s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital Partners LP11/17/2026
/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital GP LLC11/17/2026
/s/ Mark Shamia, Chief Operating Officer of Coastlands Capital LLC11/17/2026
/s/ Matthew D. Perry11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading